ClinicalTrials.gg
DrugRead study by study

Ceralasertib clinical trials

Also written AZD6738.

studies test it
46
open now
8
in phase 3
2
first study started
2014
ClinicalTrials.gov finds 47 studies for ceralasertib. How that becomes 46 here

Every study that search finds has been read, to see whether and how it gives ceralasertib. ClinicalTrials.gov counts as of Nov 16, 2026. How drug pages count

  1. 47Found by its intervention search · See all 47 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 31 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. 47Give ceralasertib to participants
  3. −1Give it beside what is tested
  4. 46Test it: the count on this site

Get an email when these change. Save the ceralasertib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ceralasertib
26

Development codes

AZD6738
33

Other names

ATR Kinase Inhibitor AZD6738
1

Studies by the year they started

46 studies that test it; most in 2019 (8)

Studies that test ceralasertib, by start year
YearStudies
20142
20152
20163
20172
20187
20198
20208
20213
20225
20231
20255

By phase

A phase 1/2 study counts in both.

Phase 1
15
Phase 2
30
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 30

AstraZeneca (14) · National Cancer Institute (NCI) (3) · Samsung Medical Center (3) · Institute of Cancer Research, United Kingdom (3) · M.D. Anderson Cancer Center (2) · Acerta Pharma BV (2) · Seoul National University Hospital (2) · Massachusetts General Hospital (1)

Often tested with

Tested in the same studies.

Olaparib (7) · Durvalumab (5) · Adavosertib (4) · Capivasertib (4) · Vistusertib (3) · AZD 6244 (3) · Danvatirsen (2) · Oleclumab (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

New treatments tested with it · 1 most studied

New when their studies opened, with ceralasertib beside them; studies of each.

Reaching primary completion within a year · 4

Studies that test ceralasertib.

Studies

Open first, then newest update. How each study uses ceralasertib has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 46

See all 46 studies that test ceralasertib →

Tested on its own · 4 — no other medicine in its arm
Tested with established drugs · 24 — they are given beside it

Showing 20 of 24. See all 24 →

Tested in a combination · 16 — another drug in the study is under test too
Beside a new treatment under test · 1 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with ceralasertib: capivasertib 1

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call ceralasertib · ClinicalTrials.gg INT000556

  • MeSH (NLM) C000611951ceralasertibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 85RE35306ZCERALASERTIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27896182ceralasertibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C111993CeralasertibOne source FDA
  • DrugBank DB14917One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion